Bifidobacterium breve PRL2020: Antibiotic-Resistant Profile and Genomic Detection of Antibiotic Resistance Determinants.
Francesco Di PierroIlenia CampedelliPatrick De MartaFabio FracchettiAntonio Del CasaleIlaria CavecchiaMariarosaria MateraMassimiliano CazzanigaAlexander BertuccioliLuigina GuastiNicola ZerbinatiPublished in: Microorganisms (2023)
Antibiotics are one of the greatest scientific achievements of modern medicine, but excessive use is creating challenges for the future of medicine. Antibiotic resistance (AR) is thought to cause changes in bowel habits and an increased risk of gastroenteritis, but it may also increase the risk of overweight, obesity, autoimmune and atopic diseases, and a low response to vaccines and cancer, likely mediated by antibiotic-induced gut dysbiosis. Probiotic add-on therapy could partially prevent antibiotic-induced gut dysbiosis, but their antibiotic sensitivity features likely limits this potential. The EFSA (European Food Safety Authority) guidelines consider the use of probiotics whose antibiotic-resistant profile could be transferable an important hazard. Recently, a strain of B. breve (PRL2020) has shown to be resistant to amoxicillin and amoxicillin-clavulanate (AC) by applying the microdilution protocol according EFSA guidelines. After verifying that horizontal gene transfer is unlikely to take place, this feature suggests its concomitant use with these specific antibiotics. The results of our tests demonstrated that the strain PRL2020 is indeed endowed with amoxicillin- and AC-resistant properties and that it is also insensitive to ampicillin. In-depth analysis of the annotated genome sequence of B. breve PRL2020 was employed to query the Comprehensive Antibiotic Resistance Database (CARD) using Resistance Gene Identifier (RGI) software (version 5.2.1). The similarity among the AR determinants found was studied through nucleotide sequence alignment, and it was possible to verify not only the absence of genes explaining these features in the flanking regions but also the presence of genetic sequences ( rpoB and erm(X) ) putatively responsible for rifampicin and erythromycin resistance. Both features are not phenotypically expressed, and for these antibiotics, the strain is within the EFSA limits. Analysis of the flanking regions of these genes revealed possible mobile elements upstream and downstream only in the case of the erm(X) gene, but the features of the Insertion Sequences (IS) are described as not to cause horizontal transfer. Our findings on strain PRL2020 demonstrate that its AR profile is compatible with antibiotics when taken with the aim of reducing the risk of dysbiosis.
Keyphrases
- genome wide
- copy number
- genome wide identification
- weight gain
- weight loss
- high glucose
- dna methylation
- type diabetes
- metabolic syndrome
- insulin resistance
- physical activity
- drug induced
- genome wide analysis
- diabetic rats
- gene expression
- multiple sclerosis
- transcription factor
- papillary thyroid
- mycobacterium tuberculosis
- mesenchymal stem cells
- endothelial cells
- body mass index
- skeletal muscle
- emergency department
- stem cells
- climate change
- bone marrow
- oxidative stress
- squamous cell carcinoma
- bioinformatics analysis
- psychometric properties
- stress induced
- genetic diversity
- data analysis
- lactic acid